Immunogenicity Research of SARS-CoV-2 mRNA Vaccine
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes significant morbidity and mortality, particularly among vulnerable immunosuppressed cancer patients. From observational studies, messenger RNA (mRNA) SARS-CoV-2 vaccines, BNT162b2, and mRNA-1273 show reduced antibody response in cancer patients compared to healthy individuals. Visit-

comments (0)

NJ, United States

81 more from synbiotech